FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to hydrochloride salt, citrate salt, phosphate salt or sulphate salt of compound 1, as well as to crystalline forms of said salts and a method for production thereof.
EFFECT: disclosed compound is intended for preparing a medicament for treating cerebral stroke or epilepsy.
20 cl, 9 tbl
| Title |
Year |
Author |
Number |
| CRYSTALLINE FORM OF THIOPHENE DERIVATIVE AND METHOD FOR OBTAINING THEREOF |
2022 |
- Zhang, Yang
- Wu, Wentao
- Li, Zhixiang
- Zhu, Wenyuan
|
RU2830948C1 |
| CRYSTALLINE OR AMORPHOUS FORM OF FXR AGONISTS BEING STEROID DERIVATIVES, THEIR PRODUCTION METHOD AND THEIR USE |
2018 |
- Li, Syaolin
- Syao, Khualin
- Li, Pen
- Khe, Khajin
- Li, Vejdun
|
RU2800751C2 |
| LSD1 INHIBITOR SALT AND ITS POLYMORPHIC FORM |
2019 |
- Chzhao, Lele
- Sun, Tszyantszyun
- Vu, Linyun
- Chen, Shukhuej
|
RU2794977C2 |
| SALT FORM OF ISOQUINOLINONE TYPE COMPOUND AS ROCK INHIBITOR AND METHOD FOR ITS PREPARATION |
2021 |
- Ge, Jian
- Wang, Yandong
- Liu, Yizhi
- Wu, Lingyun
- You, Xu
- Xiao, Zheming
- Chen, Shuhui
|
RU2821792C1 |
| SOLID FORM, CRYSTALLINE, AND CRYSTALLINE A OF FXR AGONIST AND METHOD FOR THEIR PRODUCTION AND THEIR APPLICATION |
2019 |
- Li, Xiaolin
- Li, Peng
- He, Haiying
|
RU2804320C2 |
| INDAZOLE DERIVATIVE SALTS AND THEIR CRYSTALS |
2017 |
|
RU2747399C2 |
| COMPOUND OF BRD4 INHIBITOR IN SOLID FORM, METHOD FOR ITS PRODUCTION AND APPLICATION |
2020 |
- Shen, Chunli
- Lyu, Yun
- Byan, Khuanyuj
- Vu, Chende
- Vu, Tszyakhu
|
RU2793346C1 |
| CRYSTAL FORM OF PHOSPHODIESTERASE INHIBITOR, METHOD OF ITS PREPARATION AND USE |
2020 |
|
RU2814498C2 |
| ACID ADDITION SALT OF TRK INHIBITING COMPOUND |
2015 |
- Takeuchi, Jun
- Itadani, Satoshi
- Ikura, Masahiro
- Higashino, Masato
- Kijima, Hideomi
- Ono, Shizuka
- Yasuhiro, Tetsuya
- Nagaura, Takeshi
|
RU2708236C2 |
| COMPOUND OF FGFR INHIBITOR IN SOLID FORM AND METHOD OF ITS PREPARATION |
2020 |
- Fu Zhifei
- Luo Miaorong
- Sun Jikui
- Zhang Yang
- Li Jian
- Chen Shuhui
|
RU2810067C2 |
